NASDAQ:VABK - Nasdaq - US9280311039 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
2022 | 2023 | 2024 | ||
---|---|---|---|---|
Revenue YoY % growth | 67.21M 21.19% | 58.07M -13.60% | 53.965M -7.07% | |
EBITDA YoY % growth | N/A | N/A | N/A | |
EBIT YoY % growth | N/A | N/A | N/A | |
Operating Margin | N/A | N/A | N/A | |
EPS YoY % growth | N/A | N/A | N/A |
All data in USD
EPS Q2Q % growth |
---|
Revenue Q2Q % growth |
EBITDA Q2Q % growth |
EBIT Q2Q % growth |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2022 Q2Q % growth | 1.32 51.72% | % | ||
Q2 2022 Q2Q % growth | 1.06 19.10% | % |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2024 Q2Q % growth | 14.503M 12.52% | % | ||
Q3 2024 Q2Q % growth | 13.476M -1.92% | % | ||
Q2 2024 Q2Q % growth | 12.872M -18.27% | % | ||
Q1 2024 Q2Q % growth | 13.114M -16.42% | % | ||
Q4 2023 Q2Q % growth | 12.889M -29.61% | % | ||
Q3 2023 Q2Q % growth | 13.74M -17.13% | % | ||
Q2 2023 Q2Q % growth | 15.75M -2.23% | % | ||
Q1 2023 Q2Q % growth | 15.69M -3.27% | % | ||
Q4 2022 Q2Q % growth | 18.31M 18.97% | % | ||
Q3 2022 Q2Q % growth | 16.58M -2.36% | % | ||
Q2 2022 Q2Q % growth | 16.11M 0.25% | % | ||
Q1 2022 Q2Q % growth | 16.22M 131.38% | % | ||
Q4 2021 Q2Q % growth | 15.39M 80.00% | % | ||
Q3 2021 Q2Q % growth | 16.98M 127.01% | % | ||
Q2 2021 Q2Q % growth | 16.07M 117.46% | % | ||
Q1 2021 Q2Q % growth | 7.01M -0.57% | % | ||
Q4 2020 Q2Q % growth | 8.55M 24.09% | % | ||
Q3 2020 Q2Q % growth | 7.48M 10.00% | % | ||
Q2 2020 Q2Q % growth | 7.39M 3.21% | % | ||
Q1 2020 Q2Q % growth | 7.05M 6.33% | % |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | N/A | N/A | N/A | N/A |
Revenue | N/A | N/A | N/A | N/A |